Valuation: Yunnan Botanee Bio-Technology Group Co.LTD

Market Cap 13.35B 1.97B 1.72B 1.59B 1.47B 2.78B 188B 2.83B 18.99B 7.46B 92.54B 7.4B 7.23B 318B P/E 2026 *
21x
P/E 2027 * 18.2x
Enterprise Value 11.7B 1.73B 1.51B 1.39B 1.29B 2.44B 165B 2.48B 16.64B 6.53B 81.09B 6.48B 6.34B 279B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.75x
Free-Float
50.21%
Yield 2026 *
2.34%
Yield 2027 * 2.47%
05-21 Yunnan Botanee Bio-Technology Group Co.LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2025, Payable on 28 May 2026 CI
04-29 Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
04-28 Jefferies Adjusts Yunnan Botanee Bio-Technology's Price Target to 40 Yuan from 42 Yuan, Keeps at Hold MT
04-26 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan. CI
03-02 Yunnan Botanee Bio-Technology Group Co.LTD Approves Cash Dividend on A Shares for the Third Quarter of 2025, Payable on 10 March 2026 CI
02-11 Yunnan Botanee Bio-Technology Group Co.Ltd Proposes Dividend for the Third Quarter of 2025 CI
01-12 Yunnan Botanee Bio-Technology Group's shareholder plans to cut stake RE
12-09 Suzhou Zisong Medical Technology Co., Ltd announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD, Beijing Zhongguancun Qihang Venture Capital and other investors CI
27/10/25 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
29/08/25 Macquarie Downgrades Yunnan Botanee Bio-Technology Group to Underperform from Outperform; Price Target is 42 Yuan MT
27/08/25 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2025 CI
24/07/25 Yunnan Botanee Bio-Technology's shareholder to unload shares RE
1 day+2.42%
1 week-1.61%
Current month+0.60%
1 month-5.46%
3 months-15.60%
6 months-23.06%
Current year-19.97%
1 week 30.58
Extreme 30.58
32.54
1 month 29.48
Extreme 29.48
34.24
Current year 29.48
Extreme 29.48
49.79
1 year 29.48
Extreme 29.48
51.8
3 years 29.48
Extreme 29.48
109.3
5 years 29.48
Extreme 29.48
277.02
10 years 29.48
Extreme 29.48
289.35
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2016
Director of Finance/CFO 44 05/03/2019
Corporate Officer/Principal 47 27/02/2023
Director TitleAgeSince
Chairman 63 31/05/2014
Director/Board Member 50 31/10/2012
Director/Board Member 44 31/05/2014
Change 5-day change 1-year change 3-year change Capi.($)
+2.42%-1.61%-28.26%-65.02% 1.97B
+0.36%-0.38%-0.33%-6.15% 233B
-0.89%-3.73%+35.46% - 50.25B
+2.60%-1.96%+133.21% - 9.35B
+0.20%-0.51%+9.24%-56.07% 6.82B
+5.85%+1.57%-9.88%+29.58% 5.07B
+1.31%+0.43%-33.47%-31.68% 4.56B
+0.73%-0.09%-12.61%-11.50% 3.82B
+1.25%-3.66%-30.37%-46.35% 3.34B
+0.63%+0.02%-23.08%-48.09% 2.58B
Average +1.45%-0.65%+3.99%-29.41% 32.03B
Weighted average by Cap. +0.35%-0.90%+7.95%-8.66%

Financials

2026 *2027 *
Net sales 6.05B 893M 781M 720M 665M 1.26B 85.13B 1.28B 8.6B 3.38B 41.94B 3.35B 3.28B 144B 6.63B 978M 855M 789M 729M 1.38B 93.27B 1.41B 9.43B 3.7B 45.95B 3.67B 3.59B 158B
Net income 640M 94.42M 82.58M 76.17M 70.35M 133M 9B 136M 910M 357M 4.44B 355M 347M 15.25B 737M 109M 95.13M 87.75M 81.04M 154M 10.37B 156M 1.05B 412M 5.11B 408M 399M 17.57B
Net Debt -1.65B -244M -213M -197M -182M -345M -23.26B -351M -2.35B -923M -11.46B -916M -896M -39.39B -1.74B -257M -225M -207M -192M -363M -24.51B -370M -2.48B -973M -12.08B -965M -944M -41.52B
Logo Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co Ltd is a China-based company mainly engaged in the production of cosmetics. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care. The Company primarily operates in the domestic market.
Employees
3,574
Date Price Change Volume
10/07/26 CN¥31.70 +2.42% 7,390,132
09/07/26 CN¥30.95 -1.43% 5,108,132
08/07/26 CN¥31.40 +0.35% 6,625,047
07/07/26 CN¥31.29 -2.07% 5,132,500
06/07/26 CN¥31.95 -0.84% 6,150,133
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
31.70CNY
Average target price
45.36CNY
Spread / Average Target
+43.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300957 Stock